ClinicalTrials.gg
Enrolling by invitationNCT06686875Chron Pain LSGUpdated Jan 31, 2025

Chronic Abdominal Pain After Laparoscopic Sleeve Gastrectomy

An observational study in Obesity, Chronic Pain and Abdominal Pain, sponsored by Medical University of Warsaw. Enrolling by invitation at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-31.

Sponsored by Medical University of Warsaw · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 162 studies in Obesity with a site in Poland — 46 open to participants now, 73 under way, 44 of them phase 3. Obesity · Poland.

Planned enrollment
10th of 26
200 · median 183
Started
2024
with 10 others
Observational
26 of 162
8 open now
Primary completion
2025-04
later than 4 of 72 live
Registered
95th of 162
by date
Lead sponsor
8 of 162
Medical University of Warsaw

Among the 162 studies in Obesity with a site in Poland, this one is the 10th largest by planned enrollment of the 26 observational ones that give a count, is one of 11 that started in 2024, is one of 26 observational ones, reaches primary completion later than 4 of the 72 other live ones, and was the 95th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

46 of the 162 studies in Obesity with a site in Poland are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 162 studies in Obesity with a site in Poland, or all of them as a file.
02

Study summary

The study aims to evaluate the prevalence of postoperative chronic pain, defined as the persistence of abdominal pain for more than 3 months after laparoscopic sleeve gastrectomy.

Read the detailed description

The main goal of this study is to determine the incidence of chronic abdominal pain among patients who have undergone laparoscopic sleeve gastrectomy. Patients who underwent this type of surgery at the Department of General Surgery and Transplantology of the Medical University of Warsaw between January 2020 and August 2024 will be qualified for the study. The participants will be asked to complete an online questionnaire, including a pain scale and PainDETECT Questionnaire.

03

Conditions studied

  • Obesity
  • Chronic Pain
  • Abdominal Pain

Keywords

  • laparoscopic sleeve gastrectomy
  • chronic postoperative pain
  • neuropathic pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent surgery at the Department of General Surgery and Transplantology of the Medical University of Warsaw between January 2020 and December 2024

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who underwent laparoscopic sleeve gastrectomy 3 months to 5 years earlier

Exclusion criteria

Exclusion Criteria:

  • Lack of patient consent to participate in the survey
  • No possibility to contact the patient
  • Revisional procedures
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Post surgical group

    Other: Questionnaire

Interventions

  • OtherQuestionnaire

    Patients will receive a link to a web-based questionnaire on the prevalence and characteristics of pain symptoms including the PainDETECT questionnaire.

06

What researchers measure

Primary outcomes

  1. The presence of chronic abdominal pain after laparoscopic sleeve gastrectomy

    The presence of pain after laparoscopic sleeve gastrectomy, which persists more than 3 months postoperatively.

    Time frame: Baseline

Secondary outcomes

  1. PainDETECT Questionnaire score

    PainDETECT is a simple, easy-to-use screening questionnaire. The questionnaire consists of 9 items and is completed by the patient. There are 7 weighted sensory descriptor items (never to very strongly) and 2 items relating to spatial and temporal pain characteristics. A total score of 19 or more is indicative of likely neuropathic pain.

    Time frame: Baseline

07

Study locations

1 site
  • Medical University in Warsaw
    Warsaw, 02-091, Poland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Apr 2025, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2024
First posted
Nov 13, 2024
StartActual
Dec 1, 2024
Primary completionEst.
Apr 1, 2025
CompletionEst.
May 1, 2025
Last update
Jan 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06686875
Responsible party
Piotr Mieszczanski (Principal Investigator, Medical University of Warsaw) — Principal investigator
First posted
Nov 13, 2024
Start date
Dec 1, 2024
Primary completion
Apr 1, 2025 (estimated)
Completion
May 1, 2025 (estimated)
Last update
Jan 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion